# Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever

> **NCT00125008** · PHASE4 · COMPLETED · sponsor: **International Vaccine Institute** · enrollment: 37673 (actual)

## Conditions studied

- Typhoid
- Paratyphoid Fever

## Interventions

- **BIOLOGICAL:** Typhoid Vi vaccine
- **BIOLOGICAL:** Hepatitis A vaccine

## Key facts

- **NCT ID:** NCT00125008
- **Lead sponsor:** International Vaccine Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 37673 (ACTUAL)
- **Last updated:** 2008-08-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00125008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00125008, "Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00125008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*